Solubility of valdecoxib in the presence of glycerol, propylene glycol, and poly(ethylene glycol) 400 at (298.15, 303.15, and 308.15) K

Journal of Chemical and Engineering Data

Volumn 50, Issue 5, 2005, Pages 1736-1739

  Liu, Chengsheng ^a   Desai, Kashappa Goud H ^b   Chen, Xiguang ^a   Tang, Xuexi ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MIXTURES; ORGANIC COMPOUNDS; SOLUTIONS; ULTRAVIOLET SPECTROSCOPY;

MASS FRACTION; PROPYLENE GLYCOL; SPECTRAL MEASUREMENTS; VALDECOXIB;

SOLUBILITY;

EID: 25644455129     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je050190z     Document Type: Article

References (17)

1. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
2. Yalkwosky, S. H.; Valvani, S. C. Solubility and partitioning: solubility of nonelectrolytes in water. J. Pharm. Sci. 1980, 69, 912-922.
3. Hoerter, D.; Dressman, J. B. Influence of physiochemical properties on dissolution of drugs in the gastrointestinal tract (review). Adv. Drug Del. Rev. 1997, 25, 3-14.
4. Strickley, R. G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004, 21, 201-230.
5. Mani, N.; Jun, H. W.; Beach, J. W.; Nerukar, J. Solubility of guaifenesin in the presence of common pharmaceutical additives. Pharm. Dev. Technol. 2003, 8, 385-396.
6. Liu, C.; Desai, K. G. H.; Liu, C. Solubility of rofecoxib in the presence of mannitol, poly(vinyl pyrrolidone) K30, urea, poly(ethylene glycol) 4000, and poly(ethylene glycol) 6000 at (298.15, 303.15, and 308.15) K. J. Chem. Eng. Data 2005, 50, 661-665.
7. Liu, C.; Desai, K. G. H.; Liu, C. Solubility of valdecoxib in the presence of poly(ethylene glycol) 4000, poly(ethylene glycol) 6000, poly(ethylene glycol) 8000, and poly(ethylene glycol) 10 000 at (298.15, 303.15, and 308.15) K. J. Chem. Eng. Data 2005, 50, 278-282.
8. Yalkowsky, S. H.; Rubino, J. T. Solubilization of cosolvents 1: Organic solutes in propylene glycol-water mixtures. J. Pharm. Sci. 1985, 74, 416-421.
9. Millard, J. W.; Alvarez-Nunez, F. A.; Yalkowsky, S. H. Solubilization by cosolvents: establishing useful constants for the loglinear model. Int. J. Pharm. 2002, 245, 153-166.
10. Ran, Y.; Zhao, L.; Xu, Q.; Yalkowsky, S. H. Solubilization of cyclosporin A. AAPS Pharm. Sci. Tech. 2001, 2, article 2.
11. Ormrod, D.; Wellington, K.: Wagstaff, A. J. Valdecoxib. Drugs 2002, 62, 2059-2071.
12. Dannhardt, G.; Kiefer, W. Cyclooxygenase inhibitors - current status and future prospects. Eur. J. Med. Chem. 2001, 36, 109-126.
13. Millard, J. W.; Alvarez-Nunez, F. A.; Yalkowsky, S. H. Solubilization by cosolvents: establishing useful constants for the loglinear model. Int. J. Pharm. 2002, 245, 153-166.
14. Desai, K. G. H.; Kulkarni, A. R.; Aminabhavi, T. M. Solubility of rofecoxib in the presence of methanol, ethanol, and sodium lauryl sulfate at (298.15, 303.15, and 308.15) K. J. Chem. Eng. Data 2003, 48, 942-945.
15. Tang, L.; Khan, S. U.; Muhammad, N. A. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity. Pharm. Dev. Technol. 2001, 6, 531-540.
16. Seedher, N.; Bhatia, S. Solubility enhancement of Cox-2 inhibitors using various solvents systems. AAPS Pharm. Sci. Tech. 2003, 4, article 33.
17. Damian, F.; Blaton, N.; Naesens, L.; Balzarini, J.; Kinget, R.; Augustinjns, P.; Mooter, G. V. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and gelucire 44/14. Eur. J. Pharm. Sci. 2000, 10, 311-322.